Drugs / IgY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01455675 | Oct 2011 → Jun 2017 | cystic fibrosis | Mukoviszidose Institut gGmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IgY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01455675 ↗ |
| Modality | Protein / enzyme biologic | “Avian polyclonal anti-pseudomonas antibodies (IgY)” NCT01455675 ↗ |
| Route | Other | “the investigational drug and the reference placebo group are gargled and swallowed” NCT01455675 ↗ |